A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats
Year: 2014
Type: article
Source: Neuropharmacology
Authors: Ajeesh Koshy Cherian, Howard Gritton, David E. Johnson, Damon Young, Rouba Kozak, Martin Sarter
Institutions: University of Michigan, Pfizer (United States)
Language: English
Subfield: Biological Psychiatry
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W2037599428
